Autoimmune disease. a problem of defective apoptosis
1994; Wiley; Volume: 37; Issue: 10 Linguagem: Inglês
10.1002/art.1780371002
ISSN1529-0131
AutoresJohn D. Mountz, Jian Wu, Jianhua Cheng, Tong Zhou,
Tópico(s)Systemic Lupus Erythematosus Research
ResumoArthritis & RheumatismVolume 37, Issue 10 p. 1415-1420 ReviewFree to Read Autoimmune disease. a problem of defective apoptosis John D. Mountz MD, PhD, Corresponding Author John D. Mountz MD, PhD Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterThe University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, 701 South 19th Street, UAB Station, LHRB 473, Birmingham, AL 35294–0007Search for more papers by this authorJianguo Wu PhD, Jianguo Wu PhD Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterSearch for more papers by this authorJianhua Cheng MD, Jianhua Cheng MD Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterSearch for more papers by this authorTong Zhou, Tong Zhou Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterSearch for more papers by this author John D. Mountz MD, PhD, Corresponding Author John D. Mountz MD, PhD Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterThe University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, 701 South 19th Street, UAB Station, LHRB 473, Birmingham, AL 35294–0007Search for more papers by this authorJianguo Wu PhD, Jianguo Wu PhD Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterSearch for more papers by this authorJianhua Cheng MD, Jianhua Cheng MD Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterSearch for more papers by this authorTong Zhou, Tong Zhou Multipurpose Arthritis and Musculoskeletal Disease Center, The University of Alabama at Birmingham, and the Birmingham Veterans Administration Medical CenterSearch for more papers by this author First published: October 1994 https://doi.org/10.1002/art.1780371002Citations: 167AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317, 1992 10.1038/356314a0 CASPubMedWeb of Science®Google Scholar 2 Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 125: 871–876, 1992 PubMedWeb of Science®Google Scholar 3 Adachi M, Watanabe-Fukunaga R, Nagata S: Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A 90: 1756–1761, 1993 10.1073/pnas.90.5.1756 CASPubMedWeb of Science®Google Scholar 4 Wu J, Zhou T, He J, Mountz JD: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178: 461–468, 1993 10.1084/jem.178.2.461 CASPubMedWeb of Science®Google Scholar 5 Chu J-L, Drappa J, Parnassa A, Elkon KB: The defect of Fas mRNA expression in MRL-lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 178: 723–730, 1993 10.1084/jem.178.2.723 CASPubMedWeb of Science®Google Scholar 6 Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews J, Thomas ML, Beier DR: Mutation at murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445–1454, 1993 10.1016/0092-8674(93)90369-2 CASPubMedWeb of Science®Google Scholar 7 Tsui HW, Siminovitch KA, de Souza L, Tsui FW: Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet 4: 124–129, 1993 10.1038/ng0693-124 CASPubMedWeb of Science®Google Scholar 8 Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969–976, 1994 10.1016/0092-8674(94)90375-1 CASPubMedWeb of Science®Google Scholar 9 Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301–305, 1989 10.1126/science.2787530 CASPubMedWeb of Science®Google Scholar 10 Debatin KM, Goldmann CK, Bamford R, Waldmann TA, Krammer PH: Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia. Lancet 335: 497–500, 1990 10.1016/0140-6736(90)90735-N PubMedWeb of Science®Google Scholar 11 Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Identification of a soluble form of the fas molecule that protects cells from fas-mediated apoptosis. Science 263: 1759–1761, 1994 10.1126/science.7510905 CASPubMedWeb of Science®Google Scholar 12 Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death and maturity. Annu Rev Immunol 10: 267–293, 1992 10.1146/annurev.iy.10.040192.001411 CASPubMedWeb of Science®Google Scholar 13 Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci U S A 90: 786–789, 1993 10.1073/pnas.90.3.786 CASPubMedWeb of Science®Google Scholar 14 Liu Z-G, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA: Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene Nur77. Nature 367: 281–284, 1994 10.1038/367281a0 CASPubMedWeb of Science®Google Scholar 15 Woronica JD, Cainan B, Ngo V, Winoto A: Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367: 277–280, 1994 10.1038/367277a0 PubMedWeb of Science®Google Scholar 16 Russell JH, Wang R: Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur J Immunol 23: 2379–2382, 1993 10.1002/eji.1830230951 CASPubMedWeb of Science®Google Scholar 17 Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178: 2231–2235, 1993 10.1084/jem.178.6.2231 CASPubMedWeb of Science®Google Scholar 18 Yoon JK, Lau LF: Transcriptional activation of the inducible nuclear receptor gene Nur77 by nerve growth factor and membrane depolarization in PC12 cells. J Biol Chem 268: 9148–9155, 1993 CASPubMedWeb of Science®Google Scholar 19 Su X, Zhou T, Wu J, Jope R, Mountz JD: Dephosphorylation of a 65 kD protein delivers a signal for Fas-mediated apoptosis (abstract). FASEB J 8: A218, 1994 Web of Science®Google Scholar 20 Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552–554, 1992 10.1038/359552a0 CASPubMedWeb of Science®Google Scholar 21 Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554–556, 1992 10.1038/359554a0 CASPubMedWeb of Science®Google Scholar 22 Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR: Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257: 212–214, 1992 10.1126/science.1378649 CASPubMedWeb of Science®Google Scholar 23 Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849–852, 1993 10.1038/362849a0 CASPubMedWeb of Science®Google Scholar 24 Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847–849, 1993 10.1038/362847a0 CASPubMedWeb of Science®Google Scholar 25 Lee JM, Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci U S A 90: 5742–5746, 1993 10.1073/pnas.90.12.5742 CASPubMedWeb of Science®Google Scholar 26 Wyllie AH: Apoptosis. Br J Cancer 67: 205–208, 1993 10.1038/bjc.1993.40 PubMedWeb of Science®Google Scholar 27 Arends MJ, McGregor AH, Toft NJ, Brown EJ, Wyllie AH: Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68: 1127–1133, 1993 10.1038/bjc.1993.492 CASPubMedWeb of Science®Google Scholar 28 Zacharchuk CM, Mercep M, June CH, Weissman AM, Ashwell JD: Variations in thymocyte susceptibility to clonal deletion during ontogeny: implications for neonatal tolerance. J Immunol 147: 460–465, 1991 CASPubMedWeb of Science®Google Scholar 29 Wyllie AH, Arends MJ, Morris RG, Walker SW, Evan G: The apoptosis endonuclease and its regulation. Semin Immunol 4: 389–397, 1992 CASPubMedGoogle Scholar 30 Montague JW, Gaido ML, Frye C, Cidlowski JA: A calciumdependent nuclease from apoptotic rat thymocytes is homologous with cyclophilin. J Biol Chem 269: 18877–18881, 1994 CASPubMedWeb of Science®Google Scholar 31 Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5: 625–630, 1993 10.1093/intimm/5.6.625 CASPubMedWeb of Science®Google Scholar 32 Debatin KM, Goldman CK, Waldmann TA, Krammer PH: APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81: 2972–2977, 1993 PubMedWeb of Science®Google Scholar 33 Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL: Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412–1418, 1993 10.1093/jnci/85.17.1412 PubMedWeb of Science®Google Scholar 34 Linnik MD, Zobrist RH, Hatfield MD: Evidence supporting a role for programmed cell death in focal cerebralischemia in rats. Stroke 24: 2002–2009, 1993 10.1161/01.STR.24.12.2002 CASPubMedWeb of Science®Google Scholar 35 Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M, Wallach D: Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 36: 1111–1120, 1993 10.1002/art.1780360812 CASPubMedWeb of Science®Google Scholar 36 Harrington L, Affleck G, Urrows S, Tennen H, Higgins P, Zautra A, Hoffman S: Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis. Arthritis Rheum 36: 199–203, 1993 10.1002/art.1780360209 CASPubMedWeb of Science®Google Scholar 37 Rubin LA: The soluble interleukin-2 receptor in rheumatic disease. Arthritis Rheum 33: 1145–1148, 1990 10.1002/art.1780330814 CASPubMedWeb of Science®Google Scholar 38 Gmelig-Meyling F, Dawisha S, Steinberg AD: Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus. J Exp Med 175: 297–300, 1992 10.1084/jem.175.1.297 PubMedWeb of Science®Google Scholar 39 Jones ST, Denton J, Holt PJ, Freemont AJ: Possible clearance of effete polymorphonuclear leucocytes from synovial fluid by cytophagocytic mononuclear cells: implications for pathogenesis and chronicity in inflammatory arthritis. Ann Rheum Dis 52: 121–126, 1993 10.1136/ard.52.2.121 CASPubMedWeb of Science®Google Scholar 40 Lee FD: Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 46: 118–122, 1993 10.1136/jcp.46.2.118 CASPubMedWeb of Science®Google Scholar 41 Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501, 1992 10.1083/jcb.119.3.493 CASPubMedWeb of Science®Google Scholar 42 Lu QL, Poulsom R, Wong L, Hanby AM: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169: 431–437, 1993 10.1002/path.1711690408 PubMedWeb of Science®Google Scholar 43 Needleman BW, Ordonez JV, Taramelli D, Alms W, Gayer K, Choi J: In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients. Arthritis Rheum 33: 842–852, 1990 10.1002/art.1780330611 PubMedWeb of Science®Google Scholar 44 Goldring SR, Stephenson ML, Downie E, Krane SM, Korn JH: Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts. J Clin Invest 85: 798–803, 1990 10.1172/JCI114506 CASPubMedWeb of Science®Google Scholar 45 Polunovsky VA, Chen B, Henke C, Snover D, Wendt C, Ingbar DH, Bitterman PB: Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 92: 388–397, 1993 10.1172/JCI116578 CASPubMedWeb of Science®Google Scholar 46 Clark RA: Regulation of fibroplasia in cutaneous wound repair. J Med Sci 306: 42–48, 1993 10.1097/00000441-199307000-00011 PubMedWeb of Science®Google Scholar 47 Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 364: 806–809, 1993 10.1038/364806a0 CASPubMedWeb of Science®Google Scholar 48 Zhou T, Jian YC, Wu J, Mountz JD: Fas+ Cos cells and anti-Fas antibody for in vivo localization of Fas/Fas ligand binding and apoptosis sites in autoimmune lpr and gld mice (abstract). Arthritis Rheum 36 (suppl 9): S52, 1993 Google Scholar 49 Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferation. Annu Rev Immunol 9: 243–269, 1991 10.1146/annurev.iy.09.040191.001331 CASPubMedWeb of Science®Google Scholar 50 Sidman CL, Marshall JD, Allen RD: Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes. Proc Natl Acad Sci U S A 86: 6279–6282, 1989 10.1073/pnas.86.16.6279 CASPubMedWeb of Science®Google Scholar 51 Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD: Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice: clues from a T cell receptor beta transgenic mouse. J Immunol 150: 3651–3667, 1993 CASPubMedWeb of Science®Google Scholar 52 Zhou T, Bluethmann H, Eldridge J, Berry K, Mountz JD: Abnormal thymocyte development and production of autoreactive T cells in TCR transgenic autoimmune mice. J Immunol 147: 466–474, 1991 CASPubMedWeb of Science®Google Scholar 53 Zhou T, Mountz JD, Edwards CK III, Berry K, Bluethmann H: Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr. J Exp Med 176: 1063–1072, 1992 10.1084/jem.176.4.1063 CASPubMedWeb of Science®Google Scholar 54 Sobel ES, Cohen PL, Eisenberg RA: lpr T cells are necessary for autoantibody production in lpr mice. J Immunol 150: 4160–4167, 1993 CASPubMedWeb of Science®Google Scholar 55 Reap EA, Sobel ES, Cohen PL, Eisenberg RA: Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J Exp Med 177: 69–78, 1993 10.1084/jem.177.1.69 CASPubMedWeb of Science®Google Scholar 56 Krieg AM, Gause WC, Gourley MF, Steinberg AD: A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J Immunol 143: 2448–2456, 1989 CASPubMedWeb of Science®Google Scholar 57 Krieg AM, Gourley MF, Steinberg AD: Association of murine lupus and thymic full-length endogenous retroviral expression maps to a bone marrow stem cell. J Immunol 146: 3002–3010, 1991 CASPubMedWeb of Science®Google Scholar 58 Mountz JD, Talal N: Retroviruses, apoptosis and autogenes. Immunol Today 14: 532–536, 1993 10.1016/0167-5699(93)90182-K CASPubMedWeb of Science®Google Scholar 59 Stransky G, Vernon J, Aicher WK, Moreland LW, Gay RE, Gay S: Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Br J Rheumatol 32: 1044–1048, 1993 10.1093/rheumatology/32.12.1044 CASPubMedWeb of Science®Google Scholar 60 Wu J, Zhou T, Zhang J, Mountz JD: Correction of autoimmune disease in CD2-fas transgenic mice. Proc Natl Acad Sci U S A 91: 2344–2348, 1994 10.1073/pnas.91.6.2344 CASPubMedWeb of Science®Google Scholar 61 Lang G, Wotton D, Owen MJ, Sewell WA, Brown MH, Mason DY, Crumpton MJ, Kioussis D: The structure of the human CD2 gene and its expression in transgenic mice. EMBO J 7: 1675–1682, 1988 10.1002/j.1460-2075.1988.tb02995.x CASPubMedWeb of Science®Google Scholar 62 Greaves DR, Wilson FD, Lang G, Kioussis D: Human CD2 3′-flanking sequences confer high-level, T cell-specific, positionindependent gene expression in transgenic mice. Cell 56: 979–986, 1989 10.1016/0092-8674(89)90631-4 CASPubMedWeb of Science®Google Scholar Citing Literature Volume37, Issue10October 1994Pages 1415-1420 ReferencesRelatedInformation
Referência(s)